AnaptysBio Inc (ANAB)

AnaptysBio (ANAB) Stock Price & Analysis


ANAB Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$16.66 - $32.44
Previous Close$17.15
Average Volume (3M)262.83K
Market Cap
Enterprise ValueN/A
Total Cash (Recent Filing)$429.49M
Total Debt (Recent Filing)$18.65M
Price to Earnings (P/E)-3.3
Nov 09, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-5.19
Shares Outstanding26,545,578
10 Day Avg. Volume296,730
30 Day Avg. Volume262,833
Standard Deviation0.20
Financial Highlights & Ratios
Price to Book (P/B)3.22
Price to Sales (P/S)131.58
Price to Cash Flow (P/CF)-4.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Price Target Upside36.34% Upside
Rating ConsensusHold
Number of Analyst Covering2



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was AnaptysBio Inc’s price range in the past 12 months?
AnaptysBio Inc lowest stock price was $16.66 and its highest was $32.44 in the past 12 months.
    What is AnaptysBio Inc’s market cap?
    Currently, no data Available
    When is AnaptysBio Inc’s upcoming earnings report date?
    AnaptysBio Inc’s upcoming earnings report date is Nov 09, 2023 which is in 47 days.
      How were AnaptysBio Inc’s earnings last quarter?
      AnaptysBio Inc released its earnings results on Aug 07, 2023. The company reported -$1.5 earnings per share for the quarter, beating the consensus estimate of -$1.695 by $0.195.
        Is AnaptysBio Inc overvalued?
        According to Wall Street analysts AnaptysBio Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does AnaptysBio Inc pay dividends?
          AnaptysBio Inc does not currently pay dividends.
          What is AnaptysBio Inc’s EPS estimate?
          AnaptysBio Inc’s EPS estimate is -$1.78.
            How many shares outstanding does AnaptysBio Inc have?
            AnaptysBio Inc has 26,545,578 shares outstanding.
              What happened to AnaptysBio Inc’s price movement after its last earnings report?
              AnaptysBio Inc reported an EPS of -$1.5 in its last earnings report, beating expectations of -$1.695. Following the earnings report the stock price went up 2.654%.
                Which hedge fund is a major shareholder of AnaptysBio Inc?
                Among the largest hedge funds holding AnaptysBio Inc’s share is Woodline Partners LP. It holds AnaptysBio Inc’s shares valued at 21M.


                  AnaptysBio Stock Smart Score

                  The AnaptysBio stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  AnaptysBio Inc

                  AnaptysBio, Inc. is a clinical stage biotechnology company, which engages in developing antibody product candidates focused on unmet medical needs in inflammation. Its pipeline includes ANB020, ANB019, and checkpoint receptor agonist antibodies. The company was founded by Andrew B. Cubitt, William J. Boyle and Nicholas B. Lydon in November 2005 and is headquartered in San Diego, CA.


                  Top 5 ETFs holding ANAB

                  Market Value
                  Smart Score
                  Vanguard Total Stock Market ETF
                  Vanguard Health Care ETF
                  Schwab U.S. Broad Market ETF
                  iShares Russell 3000 ETF
                  Vanguard Russell 3000 ETF
                  Up to five ETFs with an Outperform Smart Score that hold ANAB. The ETFs are listed according to market value of ANAB within the ETF

                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Anika Therapeutics
                  ANI Pharmaceuticals
                  Anixa Biosciences

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis